Ricky Sun
QuietNamed in filings at Bain Capital Life SciencesOn the current fund
- Board seats filed
- 5
Named in filings at Bain Capital Life SciencesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| ADARx Pharmaceuticals | Biotech & pharma | August 2023 | Caduceus Capital, Orbimed Asia Partners, Orbimed Genesis, TCG Crossover, Tcgx Asia Life Sciences, Vivo Innovation |
| Paragon Biosciences Emalex Capital | Biotech & pharma | May 2022 | Valor Siren Ventures |
| Savara | Biotech & pharma | December 2019 | None on file |
| Arcutis Biotherapeutics | Biotech & pharma | October 2019 | Caduceus Capital, Orbimed Asia Partners, Orbimed Genesis |
| Annexon | Biotech & pharma | December 2018 | Clarus |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Ricky Sun on the board, based on 5 filed seats with a verified or cited source.